Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Short-Term Debt issuancesShort-Term Debt repayments
Ratios

Conmed (CNMD) Short-Term Debt repayments (2016 - 2025)

Historic Short-Term Debt repayments for Conmed (CNMD) over the last 10 years, with Q4 2025 value amounting to $187.0 million.

  • Conmed's Short-Term Debt repayments rose 53.76% to $187.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $695.4 million, marking a year-over-year decrease of 764.52%. This contributed to the annual value of $695.4 million for FY2025, which is 764.52% down from last year.
  • Conmed's Short-Term Debt repayments amounted to $187.0 million in Q4 2025, which was up 53.76% from $171.0 million recorded in Q3 2025.
  • Conmed's Short-Term Debt repayments' 5-year high stood at $230.0 million during Q2 2024, with a 5-year trough of $72.0 million in Q1 2021.
  • Moreover, its 5-year median value for Short-Term Debt repayments was $168.5 million (2024), whereas its average is $156.6 million.
  • In the last 5 years, Conmed's Short-Term Debt repayments skyrocketed by 20689.66% in 2021 and then plummeted by 2546.43% in 2025.
  • Over the past 5 years, Conmed's Short-Term Debt repayments (Quarter) stood at $121.0 million in 2021, then increased by 4.13% to $126.0 million in 2022, then surged by 58.73% to $200.0 million in 2023, then decreased by 7.0% to $186.0 million in 2024, then grew by 0.54% to $187.0 million in 2025.
  • Its last three reported values are $187.0 million in Q4 2025, $171.0 million for Q3 2025, and $171.4 million during Q2 2025.